Table 5.
Prognostic factors associated with LRRC patients received surgery
Variables | Univariable | Multivariable | ||||
---|---|---|---|---|---|---|
|
|
|||||
Hazards ratio | 95% CI | P value | Hazards ratio | 95% CI | P value | |
Differentiation: poor vs. well/moderate | 1.16 | 0.65-2.07 | 0.61 | |||
Lymphovascular invasion: yes vs. no | 4.15 | 2.22-7.79 | < 0.001 | 3.55 | 1.72-7.35 | < 0.001 |
Surgical margin: positive vs. negative | 2.00 | 0.56-2.80 | < 0.001 | 1.97 | 0.68-3.57 | < 0.001 |
Re-neoadjuvant chemotherapy: yes vs. no | 0.60 | 0.36-0.99 | 0.04 | 0.51 | 0.16-1.68 | 0.27 |
Re-neoadjuvant radiotherapy: yes vs. no | 0.33 | 0.04-1.16 | 0.03 | 0.41 | 0.21-2.41 | 0.04 |
Adjuvant chemotherapy: Yes vs. no | 0.89 | 0.49-1.63 | 0.71 | |||
Adjuvant radiotherapy: Yes vs. no | 0.87 | 0.34-2.22 | 0.77 |